Oxford study suggests asthma treatment reduces COVID-19 hospitalisation

A new study compiled by the University of Oxford has found that early treatment for COVID-19 patients with medication commonly used for asthma could ‘significantly reduce the need for hospitalisation and urgent care. The data also suggested that inhaled budesonide, a corticosteroid used in the long-term management of asthma, could also reduce recovery times. This […]

Continue Reading